BLACK WEEKSFrascos −15% · kits −10% · resto −5%com o códigoEnvio grátis na Alemanha a partir de 200 €

Esta página foi traduzida automaticamente e pode conter erros. É falante nativo? Agradecemos o seu feedback e as suas correções.Enviar feedback

The Peptide Desk The Peptide Desk
Thymosin Alpha-1, foto do produto

Relatório laboratorial

PDF
99%
Pureza
Testado
Thymosin Alpha-1 5mg
Laboratório
Analiza Białek
Data
November 2026
Resultado
99% purity (5.33 mg measured)
Endotoxinas
4.56 EU/vial
N.º da encomenda
Palavra-passe

Testado de forma independente, verificável com a palavra-passe diretamente no laboratório.

Immune System

Thymosin Alpha-1

Immune System

Encomenda

Preço unitário - Envio grátis na Alemanha a partir de 200 € durante as Black Weeks
  • DHL com seguimento
  • Embalagem discreta

4.6 de 5 no Trustpilot73 avaliações

Num relance

Thymosin Alpha-1 em números

Os valores-chave da nossa enciclopédia.

Entrada completa da enciclopédia
Class
Immune-modulating peptidethymus-derived
Frequency
~2x per weekin phases
Form
Lyophilised powderreconstituted with BAC water
Sizes
5 to 10 mg2 sizes in the shop

Conhecimento

Tudo sobre Thymosin Alpha-1

Convém ter

O que precisa para isto

A água bacteriostática é adicionada automaticamente ao carrinho. Seringas e toalhetes com um clique.

Seringas de insulina

10 un. · 5.50 €

Toalhetes com álcool

50 un. · 10 €

Quanta água?

Unidades na seringa para o tamanho do seu frasco.

Abrir calculadora →

FAQ

Perguntas frequentes

Fontes de cada resposta: entrada da enciclopédia

Ainda tem alguma pergunta?

Escreva-nos, a nossa equipa ajuda.

Is Thymosin Alpha-1 approved?

Yes, but not everywhere. As thymalfasin it is approved in over 35 countries according to a 2009 review, mainly for hepatitis B and C and to strengthen the immune system. There is no approval in the US, ChEMBL lists the compound at phase 3.

How does Thymosin Alpha-1 work?

In cell and mouse experiments it made dendritic cells more active, the cells that show pathogens to the immune system. This ran via the receptor TLR9. At the same time it promoted regulatory T cells, which slow down excessive reactions. ChEMBL lists no confirmed mechanism in humans.

What do the sepsis trials show?

In ETASS with 361 people 26 percent died within 28 days with Thymosin Alpha-1 and 35 percent without, a difference that just missed certainty. The larger TESTS trial with 1,106 people and placebo found 23.4 versus 24.1 percent, so no difference. A possible benefit from age 60 counts only as a hint there.

Are there data on cancer?

In a trial with 488 people with advanced melanoma Thymosin Alpha-1 was added to chemo. The highest study dose was 6.4 mg. More tumours responded and median survival was 9.4 versus 6.6 months, but not statistically certain. There were no extra side effects.

Does it help in severe pancreatitis?

Not with certainty in the TRACE trial with 508 people. Infected dead tissue occurred in 15.7 percent with Thymosin Alpha-1 and 18.1 percent on placebo. The main goal was therefore not reached.

Which side effects are known?

In TESTS 66.4 percent on Thymosin Alpha-1 and 67.6 percent on placebo had an adverse event, serious events were 26.8 versus 29.3 percent. ETASS recorded no serious side effects caused by the drug. With autoimmune disease the regular entry advises restraint.

Relacionados

Produtos relacionados